CN Patent

CN121039114A — 1,5-二氢-2,4-苯二氮䓬-3-酮衍生物枸橼酸盐的晶型、制备方法及其应用

Assigned to Nhwa Pharmaceutical Corp · Expires 2025-11-28 · 0y expired

What this patent protects

本发明属于医药领域，具体涉及如式I所示化合物枸橼酸盐的晶型、制备方法，及其在医药领域的应用。

USPTO Abstract

本发明属于医药领域，具体涉及如式I所示化合物枸橼酸盐的晶型、制备方法，及其在医药领域的应用。

Drugs covered by this patent

Patent Metadata

Patent number
CN121039114A
Jurisdiction
CN
Classification
—
Expires
2025-11-28
Drug substance claim
No
Drug product claim
No
Assignee
Nhwa Pharmaceutical Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.